Intraoperative Surgical Margin Re-resection for Colorectal Liver Metastasis: Is It Worth the Effort?

Abstract

ObjectiveThis study was conducted to evaluate recurrence and survival among patients who underwent intraoperative margin re-resection for colorectal cancer liver metastases (CRLM). BackgroundAmong patients who receive intraoperative margin re-resection, the relation between final margin status, pattern of recurrence, and survival is largely unknown. MethodsThree hundred thirty-two patients who underwent hepatic resection for CRLM between 2000 and 2013 were identified. Demographics, operative data, pathologic margin status, site of recurrence, and long-term survival data were collected and analyzed. Patients were stratified in three groups based on their margin status: R0, R1, and R1 → R0. ResultsR0 resections were achieved in 247 (74.4 %) patients, 61 (18.4 %) patients had an R1 resection, whereas 24 (7.2 %) had an R1 → R0. Median survival for patients undergoing R0 resections was 50.2 (95 % confidence interval (CI) 49.2–66.2) months versus 63.0 (95 % CI 50.3–70.5) months for patients undergoing R1 resections versus 49.2 (95 % CI 29.9—NA) months for patients undergoing intraoperative margin re-resection (P > 0.05). Differences in recurrence rate and pattern were not significant between the three groups (P > 0.05). ConclusionIn the era of modern systemic chemotherapy, it seems that the impact of margin status on outcomes may be minimal compared to that of patient and tumor factors. In this scenario, margin re-resection to achieve R0 status does not improve long-term outcomes.